Yasuhiro Nakai

SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria

Yukihiro Chino, Yoshishige Samukawa, Soichi Sakai et al. · Biopharmaceutics & Drug Disposition · 2014 · 386 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches

Natilie Hosea, Wendy T. Collard, Susan Cole et al. · The Journal of Clinical Pharmacology · 2009 · 297 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Super-Resolution Mapping of Neuronal Circuitry With an Index-Optimized Clearing Agent

Meng‐Tsen Ke, Yasuhiro Nakai, Satoshi Fujimoto et al. · Cell Reports · 2016 · 268 citations · Full text

Natural Sciences, Neurobiology, Neuroscience +17

Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans

Y. Yamasaki, Ichiro Ieiri, Hiroyuki Kusuhara et al. · Clinical Pharmacology & Therapeutics · 2008 · 165 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +16

Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes

M Iwata, M Mukai, Yasuhiro Nakai et al. · The Journal of Immunology · 1992 · 125 citations · Full text

Life Sciences, Cell Biology, Immunology +16